CliffBio
small molecule

ADVAIR DISKUS 100/50

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Loss of exclusivity—loss of exclusivity
CompanyGLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE

Drug detail

Brand nameADVAIR DISKUS 100/50
Active ingredientFLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Strength0.1MG/INH;EQ 0.05MG BASE/INH
Dosage formPOWDER
RouteINHALATION
ModalitySmall molecule
FDA approvalAugust 2000
Marketing statusRX

More from GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ADVAIR DISKUS 100/50 patent cliff — loss of exclusivity — | CliffBio